MacroGenics
MGNX
#9401
Rank
S$0.11 B
Marketcap
S$1.75
Share price
-1.46%
Change (1 day)
-59.94%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): S-$0.09250

According to MacroGenics's latest financial reports the company's current EPS (TTM) is S-$0.06465. In 2024 the company made an earnings per share (EPS) of S-$1.38 a decrease over its 2023 EPS that were of S-$0.19.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$0.09250-93.31%
2024S-$1.38613.33%
2023S-$0.19-92.31%
2022S-$2.52-42.14%
2021S-$4.3636.44%
2020S-$3.19-21.84%
2019S-$4.09-24.58%
2018S-$5.42675.93%
2017S-$0.70-68.05%
2016S-$2.19168.25%
2015S-$0.81-55%
2014S-$1.813400%
2013S-$0.05172-108.68%
2012S$0.6024.49%
2011S$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Xencor
XNCR
S-$2.29 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.22-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.82-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$8.43-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.85-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.53-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.84-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA